Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
China · Delayed Price · Currency is CNY 58.36
+1.45 (2.55%)
At close: Mar 27, 2026
SHE:300049 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 258.42 | 113.29 | 101.56 | 97.89 | 95.47 |
Depreciation & Amortization | 101.43 | 91.12 | 80.9 | 72.39 | 67.05 |
Other Amortization | 3.4 | 3.99 | 9.32 | 3.92 | 1.17 |
Loss (Gain) From Sale of Assets | -0.38 | 0.31 | 0.82 | 1.86 | 3.46 |
Asset Writedown & Restructuring Costs | 8.24 | 7.7 | 4.71 | 0 | - |
Loss (Gain) From Sale of Investments | 8.46 | 23.11 | -2.53 | -4.12 | -5.74 |
Provision & Write-off of Bad Debts | - | 19.79 | 1.55 | 6.58 | 8.95 |
Other Operating Activities | 33.63 | 78.44 | 71.84 | 49.1 | 54.9 |
Change in Accounts Receivable | -120.63 | -106.26 | -24.6 | -94.93 | -85 |
Change in Inventory | -9.52 | -38.15 | -4.62 | -3.09 | 4.17 |
Change in Accounts Payable | 62.51 | 18.13 | 68.82 | 66.76 | 57.31 |
Change in Other Net Operating Assets | 7.55 | 19.42 | - | - | - |
Operating Cash Flow | 351.53 | 221.41 | 304.89 | 189.46 | 222.55 |
Operating Cash Flow Growth | 58.77% | -27.38% | 60.92% | -14.87% | 11.19% |
Capital Expenditures | -189.01 | -218.97 | -189.23 | -90.78 | -79.61 |
Sale of Property, Plant & Equipment | 4.45 | 4.97 | 2.73 | 1.86 | 2.01 |
Cash Acquisitions | - | 18.75 | 0.95 | 0.62 | -0.12 |
Divestitures | - | - | 0.83 | - | - |
Investment in Securities | -2.4 | -120.07 | -7.01 | 2.84 | -116.28 |
Other Investing Activities | -26.07 | 8.93 | 41.3 | 17.01 | 11.44 |
Investing Cash Flow | -213.03 | -306.38 | -150.43 | -68.45 | -182.56 |
Short-Term Debt Issued | - | 21.67 | 16.33 | 2.81 | 47.97 |
Long-Term Debt Issued | 12.4 | - | - | - | - |
Total Debt Issued | 12.4 | 21.67 | 16.33 | 2.81 | 47.97 |
Short-Term Debt Repaid | - | - | -11.99 | -51.13 | -69.89 |
Long-Term Debt Repaid | - | -19.72 | -9.5 | -11.36 | -14.24 |
Total Debt Repaid | - | -19.72 | -21.49 | -62.49 | -84.13 |
Net Debt Issued (Repaid) | 12.4 | 1.95 | -5.16 | -59.68 | -36.16 |
Issuance of Common Stock | - | 183.05 | - | - | 26.6 |
Repurchase of Common Stock | - | -4.07 | - | - | - |
Common Dividends Paid | -2.29 | -2.2 | -53.42 | -71.41 | -1.95 |
Other Financing Activities | -80.37 | -40.21 | -78.57 | 4.56 | 4.85 |
Financing Cash Flow | -70.26 | 138.52 | -137.14 | -126.54 | -6.65 |
Foreign Exchange Rate Adjustments | 12.26 | -3.35 | 13.06 | 12.01 | -28.52 |
Net Cash Flow | 80.49 | 50.2 | 30.38 | 6.49 | 4.82 |
Free Cash Flow | 162.51 | 2.44 | 115.66 | 98.69 | 142.94 |
Free Cash Flow Growth | 6555.09% | -97.89% | 17.20% | -30.96% | 58.11% |
Free Cash Flow Margin | 10.19% | 0.18% | 10.03% | 9.78% | 15.91% |
Free Cash Flow Per Share | 0.61 | 0.01 | 0.44 | 0.38 | 0.55 |
Cash Income Tax Paid | 135.45 | 122.56 | 102.31 | 89.39 | 52.05 |
Levered Free Cash Flow | 180.98 | -17.26 | 61.06 | 34.29 | 102.67 |
Unlevered Free Cash Flow | 180.98 | -15.53 | 61.62 | 35.28 | 104.12 |
Change in Working Capital | -61.67 | -116.33 | 36.73 | -38.17 | -2.71 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.